JMI Syringes & Medical Devices Limited announcements
208 Dhaka Stock Exchange announcements for JMI Syringes & Medical Devices Limited (JMISMDL) since 2013: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2023 (20).
- Resumption after Record Date
Trading of the shares of the company will resume on 23.11.2023.
- Suspension for record date
Trading of the shares of the company will remain suspended on record date i.e., 22.11.2023.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 20.11.2023 to 21.11.2023 and trading of the shares will remain suspended on record date i.e., 22.11.2023.
- (Q1 Un-audited): EPS was Tk. 0.08 for July-September 2023 as against Tk. 0.65 for July-September 2022; NOCFPS was Tk. 1.
(Q1 Un-audited): EPS was Tk. 0.08 for July-September 2023 as against Tk. 0.65 for July-September 2022; NOCFPS was Tk. 1.22 for July-September 2023 as against Tk. (2.30) for July-September 2022. NAV per share was Tk. 86.45 as on September 30, 2023 and Tk. 86.37 as on June 30, 2023. Reason for deviation in EPS and NOCFPS: During the reported period Net profit after Tax and Earning per Share (EPS) are decreased in comparison with previous period due to: (cont.1)
- (Continuation news of JMISMDL): i) appreciation of US Dollar against BDT, effect from war between Ukraine and Russia, in
(Continuation news of JMISMDL): i) appreciation of US Dollar against BDT, effect from war between Ukraine and Russia, increase of raw/packaging materials cost, utility cost and other related overhead. ii) Income Tax has been charged as per relevant rules and tax assessment history of the Company and the tax amount are higher than the corporate tax rate. (cont.2)
The first part of this announcement is missing from the archive. - Q1 Financials
(Continuation news of JMISMDL): During the reported period the company had several payables against the purchase of raw materials, purchase of packaging materials and other expenses resulting in a positive operating cash flow compared to the previous period. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 08, 2023 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2023.
- The Board of Directors has recommended 10\% Cash dividend for the year ended June 30, 2023. Date of AGM: 21.12.2023, Tim
The Board of Directors has recommended 10\% Cash dividend for the year ended June 30, 2023. Date of AGM: 21.12.2023, Time: 11:00 AM, Venue: Digital Platform. Record Date: 22.11.2023. The Company has also reported EPS of Tk. (4.99), NAV per share of Tk. 86.37 and NOCFPS of Tk. 2.19 for the year ended June 30, 2023 as against Tk. 3.35, Tk. 91.36 and Tk. 1.36 respectively for the year ended June 30, 2022. (cont.1)
- (Continuation news of JMISMDL): Reasons for Deviations in EPS, NOCFPS and NAVPS: EPS has been decreased due to appreciat
(Continuation news of JMISMDL): Reasons for Deviations in EPS, NOCFPS and NAVPS: EPS has been decreased due to appreciation of US Dollar against BDT, war between Ukraine and Russia, increase of raw/packaging materials cost, utility cost and other related overhead and adjustment of some advance income tax as per relevant rules. (cont.2)
The first part of this announcement is missing from the archive. - Dividend Declaration
(Continuation news of JMISMDL): NOCFPS has been increased due to decrease in accounts receivable as well as collection from sales proceeds was over with compared to the sales. NAVPS has been decreased due to Losses from operations as well as adjustment of advance income tax. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (31.10.2023) following its corporate declaration. However, the floor price shall be applicable accordingly.
- Reschedule of Board Meeting under LR 19(1)
The Company has further informed that, due to unavoidable circumstances, the Board meeting under LR 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on October 30, 2023 at 4:00 PM instead of October 23, 2023 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2023.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 23, 2023 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2023.
- Appointment of new Nominee Director representing Nipro Corporation
The company has informed that the Board of Directors of the company resolved appointment of Mr. Hiroshi Saito, Director Finance of JMI Syringes & Medical Devices Limited as Nominee Director on behalf of Nipro Corporation, Osaka, Japan instead of Mr. Katsuhiko Fujii. The Board further resolved the interim appointment of Mr. Hiroshi Saito as new Nominee Director of the Company shall be placed to the shareholders in the forthcoming AGM for taking necessary approval.
- Appointment of Independent Director
The company has informed that Board of Directors has appointed Mr. Md. Nazrul Islam, former General Manager of Janata Bank and Rupali Bank Limited as new Independent Director of the company in place of Mr. Hemayet Hossain.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.11 for January-March 2023 as against Tk. 1.03 for January-March 2022; EPS was Tk. 1.08 for July 2022-March 2023 as against Tk. 3.16 for July 2021-March 2022. NOCFPS was Tk. (1.09) for July 2022-March 2023 as against Tk. (1.71) for July 2021-March 2022. NAV per share was Tk. 92.44 as on March 31, 2023 and Tk. 91.36 as on June 30, 2022. EPS and NOCFPS has been decreased due to increased paid up capital.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 27, 2023 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2023.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.32 for October-December 2022 as against Tk. 1.50 for October-December 2021; EPS was Tk. 0.97 for July-December 2022 as against Tk. 2.13 for July-December 2021. NOCFPS was Tk. (2.85) for July-December 2022 as against Tk. (1.22) for July-December 2021. NAV per share was Tk. 92.33 as on December 31, 2022 and Tk. 91.36 as on June 30, 2022.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2023 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2022.
- Dividend Disbursement
The Company has informed that it has credited the Bonus shares for the year ended June 30, 2022 to the respective shareholders' BO Accounts.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.